What does the evidence say about Probiotic Acne Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Probiotic Acne Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Standard therapy often relies on antibiotics, but the long-term use has increased antibiotic resistance, including in Indonesia. [Lestari K (2026); evidence level 2] - Background Acne vulgaris is a chronic inflammatory condition primarily caused by Cutibacterium acnes , which disrupts skin homeostasis, thereby triggering immune responses and sebum metabolism. [Lestari K (2026); evidence level 2] - Dysbiosis is an imbalance in the skin and gut microbiota identified as a significant factor contributing to acne progression. [Lestari K (2026); evidence level 2] - Acne vulgaris is a chronic inflammatory condition with multifactorial pathogenesis. [Burckhardt-Bravo V (2026); evidence level 4] - Despite the availability of numerous treatment options, there remains a need for safe, well-tolerated, and microbiome-preserving therapies. [Burckhardt-Bravo V (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.